Semaglutide  (GLP-1 Receptor Agonist) – Premium Quality API

Product Overview

Semaglutide is a GLP-1 receptor agonist with multiple effects such as lowering blood sugar, protecting nerves and suppressing appetite. The drug achieves the effects of lowering blood sugar and reducing weight by promoting insulin secretion, inhibiting glucagon release and delaying gastric emptying.

Technical Specifications & Quality Attributes

• Purity (HPLC): ≥ 99.0%

• Identity (MS): Confirmed by HPLC/MS

• Appearance: Lyophilized white to off-white powder

• Quality Control: Rigorous CQA (Critical Quality Attributes) tracking, including mass spectrometry sequencing, mass balance verification, and residual solvent control under GMP-compliant standards.

Commercial Supply & Booking Terms

• Supply Capacity: Fully capable of Kilogram-scale (kg) commercial batch production.

• Lead Time: Due to the rigorous synthesis cycles and strict quality control protocols required for large-scale batches, a 1-month advance pre-order is required.

Regulatory & Compliance Notice

Disclaimer: This product is an active pharmaceutical ingredient (API) / chemical intermediate intended solely for laboratory research, formulation development, or further manufacturing use. It is not intended for direct human therapeutic use or direct consumer distribution. All promotion and supply adhere strictly to international and domestic advertising laws regarding pharmaceutical raw materials.